当前位置: 首页> 活动互动>后疫情时代感染性疾病的诊治与防控能力提升项目之与时俱进-指南共识下的临床实践(第二期)
辉瑞投资有限公司
发表时间:2021-03-23

3-辉瑞投资有限公司logo.jpg

辉瑞公司(Pfizer Inc.)创建于1849年,迄今已有约170年的历史,总部位于美国纽约,是以研发为基础的生物制药公司。辉瑞的目的是为患者带来改变其生活的突破创新。

2018年辉瑞公司全年合计收入536亿美元,每年研发投入约80亿美元。辉瑞在全球拥有90,000多名员工,40家生产基地,业务遍及全球125个国家和地区。

辉瑞于1989年进入中国,现已发展为在华主要的外资制药公司之一。目前在中国有约11,000名员工,业务覆盖了全国300余个城市。辉瑞在华累计投资超过15亿美元,并设立了3家先进的生产设施。

辉瑞始终致力于“成为中国医疗卫生体系的重要组成部分”,承诺并积极参与促进中国医疗卫生事业的发展和提高人民健康水平。我们志在通过创新的、富有社会责任并且商业可行的方式,满足中国人民多样化的医疗服务需求。

 

图片1.png 

 

Pfizer is one of the world’s leading research-based biopharmaceutical companies. The company was founded in 1849 in Brooklyn, NY. Our purpose: breakthroughs that change patients’ lives.

 

Pfizer’s 2018 global revenues totaled USD $53.6 billion, and the company invested approximately USD $8 billion in research and development for the year. Worldwide, Pfizer has approximately 90,000 employees, 40 global manufacturing facilities and operations in more than 125 markets.

 

Pfizer began its business operations in China in 1989 and is now one of the leading multinational biopharmaceutical companies in China, with a presence in more than 300 cities nationwide and a staff of more than 11,000. Pfizer has invested more than USD 1.5 billion in China, and established 3 state-of-the-art manufacturing facilities.

 

Pfizer is committed to be an essential part of China’s healthcare system. We promote the enhancement of Chinese people’s health and the country’s healthcare standard. We work to meet the unmet medical needs of China’s people in an innovative, socially responsible and commercially viable way.